AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05120440 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Breakfast consumption
Description: Breakfast consumption will consist of eating a standardized breakfast on the morning of afternoon resistance training performance assessment.
Study NCT04751747 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT simulation
Study NCT04751747 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Contrast Agent
Description: Given IV
Study NCT06277622 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PFUN
Description: perform preoperative preparation, intraoperative operation and internal fixation implantation according to the instructions provided in the product packaging.
Study NCT06277622 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PFNA
Description: perform preoperative preparation, intraoperative operation and internal fixation implantation according to the instructions provided in the product packaging.
Study NCT05224362 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: A repeated measures acute study using using elastic resistance bands in older adults to challenge stability.
Description: A repeated measures acute study using using elastic resistance bands in older adults to challenge stability. Exercises with an elastic resistance band anchored from the ground and placed at the hip and chest region will be trialled. Bertec force plate analysis will be performed to assess the acute effects on balance and stability. A semi- structured interview will identify the impact and practicalities of the intervention. The information will be used in the development of an evaluation process with key consideration of the planning phase of the intervention. Questions with verbal cues to provide perceptions of the exercise selection such as likes/ dislikes, safety, confidence, difficulty, enjoyment and band placement will be asked to determine the acceptability, accessibility, appropriateness and usability of the protocol and build insights into the participant preferences.
Study NCT05224362 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: A repeated measures acute study using using elastic resistance bands in older adults to challenge stability.
Description: A repeated measures acute study using using elastic resistance bands in older adults to challenge stability. Exercises with an elastic resistance band anchored from the ground and placed at the hip and chest region will be trialled. Bertec force plate analysis will be performed to assess the acute effects on balance and stability. A semi- structured interview will identify the impact and practicalities of the intervention. The information will be used in the development of an evaluation process with key consideration of the planning phase of the intervention. Questions with verbal cues to provide perceptions of the exercise selection such as likes/ dislikes, safety, confidence, difficulty, enjoyment and band placement will be asked to determine the acceptability, accessibility, appropriateness and usability of the protocol and build insights into the participant preferences.
Study NCT06147830 — intervention group
Intervention type: OTHER
Intervention: None (Observational study)
Description: Not Applicable since Observational Study
Study NCT06278857 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dostarlimab-Gxly 50 MG/1 ML Intravenous Solution [JEMPERLI]
Description: The dosing regimen follows standard clinical care protocol comprising of 4 cycles every 3-weeks, a rest period of 34 weeks followed by 3 cycles every 6 weekly for a total of 7 cycles.
Study NCT06434051 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional Chinese cervical manipulation
Description: The CMP will first palpate the transverse processes of C1 and C2. The transverse process with apparent tenderness will be regarded as the pain side. The right side will be the painful side for the following example). During the manipulation, the CMP will use his left hand to support the lower jaw and passively rotate the neck to the left side by 70-75 degrees (or to the maximum angle without discomfort). The physician's right-hand fingers will support the left-side transverse processes of C1 and C2, and the thumb and thenar muscle will be placed on the spinous process and occipital area. While maintaining a passive left neck rotation, the physician will increase the rotation angle by 5-10 degrees with both hands under a sudden pulling force. The above procedure will be repeated on the right side (pain side).
Study NCT06434051 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham manipulation
Description: The posture and position of the participant and the practitioner and the procedure are the same as the CCM technique. The right side will be regarded as the pain side once again. When performing the sham technique, the CMP uses the left hand to support the lower jaw position and passively rotates the neck to the left side by 70-75 degrees or to the maximum angle. The right hand presses the upper inner corner of the right scapula. While maintaining the passive left rotation of the neck, the right hand slowly exerts force downwards and outwards on the inner side of the scapula. The left hand only maintains the left rotation of the neck without any pulling force. After completion, repeat the above actions on the right side. After the technique is completed, participants can get up after resting for 5-10 minutes.
Study NCT04732676 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Smartphone application
Description: Ecological Momentary Assessment (EMA)~: ambulatory assessment of behaviors/symptoms in real-time on smartphones
Study NCT04732676 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Smartphone application
Description: Ecological Momentary Assessment (EMA)~: ambulatory assessment of behaviors/symptoms in real-time on smartphones
Study NCT05091164 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Drug induce sleep endoscopy of upper aerodigestive tract under hypnosis
Description: Drug induce sleep endoscopy of upper aerodigestive tract under hypnosis.
Study NCT06480656 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Rehabilitation with eccentric cycling exercise
Description: Instead of normal cycling, patients will exercise on the eccentric bike.
Study NCT06480656 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: normal rehabilitation
Description: Normal rehabilitation will be conducted
Study NCT05165290 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Latanoprost ophthalmic solution, 0.005%
Description: Commercially available, FDA-approved generic latanoprost ophthalmic solution, 0.005% (LAT) without modification will be used as the active control
Study NCT05165290 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TC-002 latanoprost ophthalmic solution, 0.005%
Description: TC-002 is formulated using the commercially available latanoprost drug substance; delivered drop to the eye is preservative-free.
Study NCT05275842 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy- Lifesteps (CPT-L)
Description: CPT-L is designed to help people with HIV and PTSD take their medications as prescribed. Cognitive Processing Therapy (CPT) uses education and cognitive training to help individuals identify thoughts and feelings about their trauma and gives them tools to help them change unhelpful beliefs. Lifesteps (L) includes education on the need for people with HIV to take their medications as prescribed and what could happen if you do not, as well as gives you tools to help motivate and remind you to take your medications on time.~Participants will receive a 12-session Cognitive Processing Therapy-Lifesteps (CPT-L) treatment program at the Ryan White clinic. The CPT-L program will be delivered twice a week for 6 weeks. Each session last about 90-minutes.
Study NCT05275842 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifesteps
Description: Lifesteps (L) includes education on the need for people with HIV to take their medications as prescribed and what could happen if you do not, as well as gives you tools to help motivate and remind you to take your medications on time.~Participants will complete one Lifesteps education session. This session lasts about 60 minutes. Participants may attend this session either in-person or over the internet if they have an internet ready device with audio.
Study NCT05275842 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Lifesteps
Description: Lifesteps (L) includes education on the need for people with HIV to take their medications as prescribed and what could happen if you do not, as well as gives you tools to help motivate and remind you to take your medications on time.~Participants will complete one Lifesteps education session. This session lasts about 60 minutes. Participants may attend this session either in-person or over the internet if they have an internet ready device with audio.
Study NCT05507281 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided Erector Spinae Plane Block
Description: ultrasound-guided ipsilateral Erector Spinae Plane Block (20 ml (19ml bupivacaine 0.25% plus 1ml dexamethasone 4mg)).
Study NCT05507281 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Retrolaminar Block
Description: ultrasound-guided ipsilateral Retrolaminar Block (20 ml (19ml bupivacaine 0.25% plus 1ml dexamethasone 4mg)).
Study NCT05507281 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Control
Description: General anesthesia
Study NCT05550922 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthcare Transition-Based Education
Description: The goal is for asthmatic adolescents to take responsibility for their own disease, be prepared for transition to adult pulmonology services, increase their self-efficacy, and gain management skills as a result of health care transition education.
Study NCT05709457 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cash transfer in prior study
Description: Women were offered a cash transfer conditional on attending prenatal and postnatal visits and delivering in a facility
Study NCT06337513 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation intervention
Description: The intervention consists of a physiotherapist-coordinated (PT) interdisciplinary outpatient rehabilitation offer for 6-months.~The intervention encompasses 3 individual sessions with the PT, if needed individual sessions with the interdisciplinary team (PT, occupational therapist, OT, nurse, and social worker) (a maximum of 6 hours), and patient education in two group seminars.
Study NCT06337513 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Both the intervention and the control group will receive usual care.
Study NCT06556498 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Proflor group
Description: evaluate the surgical outcomes of patients underwent to laparoscopic inguinal hernia repair with Proflor mesh.
Study NCT05826054 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Montbretin A
Description: The investigational product is 95% pure montbretin A (MbA), a glycosylated acyl-flavonol isolated from the corms (bulbs) of the Crocosmia plant through hot water extraction. It is a potent and specific inhibitor of human pancreatic amylase (HPA).
Study NCT06271915 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SNAGs - eccentric exercise
Description: intervention done 2 times per week, 45 minutes each session for 4 weeks
Study NCT06271915 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SNAGs - eccentric exercise
Description: intervention done 2 times per week, 45 minutes each session for 4 weeks
Study NCT06642116 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OCEAN
Description: Biodegradable nasal dressing
Study NCT05157698 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naltrexone and Bupropion Combination
Description: Participants in this intervention will take active naltrexone and bupropion pills.
Study NCT05157698 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Weight Loss
Description: Participants in this intervention will receive behavioral weight loss treatment.
Study NCT05157698 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants in this intervention will take inactive (placebo) pills.
Study NCT05157698 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants in this intervention will take inactive (placebo) pills.
Study NCT06272890 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: motivational interviewing
Description: motivational interviewing
Study NCT06418308 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: 5 mcg of dexmedetomidine
Study NCT06418308 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epinephrine
Description: 200 mcg of epinephrine
Study NCT06418308 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standardized Spinal Mixture
Description: Standardized spinal mixture of 10.25 mg hyperbaric bupivacaine, and 0.125 mg morphine.
Study NCT06556498 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Progrip group
Description: evaluate the surgical outcomes of patients underwent to laparoscopic inguinal hernia repair with Progrip mesh.
Study NCT05952934 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: 0.5 mL Candin®/injection
Description: Candin or placebo injection every 3 weeks until 4 injections then every 3 months until a total of 7 injections.
Study NCT05952934 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo: 0.5 mL Intravenous 0.9% NaCl solution (Saline)
Description: Placebo injection every 3 weeks until 4 injections then every 3 months until a total of 7 injections.
Study NCT06435728 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: AccuIMR and AccuFFR
Description: AccuFFR and AccuIMR were obtained by reviewing coronary angiography at the time of primary PCI
Study NCT06145373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fitusiran (SAR439774)
Description: Pharmaceutical form:Solution for injection-Route of administration:Subcutaneous (SC) injection
Study NCT06145373 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Clotting factor concentrates (CFC) or bypassing agents (BPA)
Description: Pharmaceutical form: Solution for injection-Route of administration: Intravenous (IV) injection
Study NCT06145373 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Antithrombin concentrate (ATIIIC)
Description: Pharmaceutical form:Solution for injection-Route of administration:Intravenous (IV) injection
Study NCT06145373 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Emicizumab
Description: Pharmaceutical form:Solution for injection-Route of administration:SC injection
Study NCT06217380 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Masimo SafetyNet Alert (MSNA)
Description: This study will explore the feasibility of implementing the Masimo SafetyNet Alert (MSNA) oxygen saturation monitoring system and the acceptance of MSNA by individuals living in a supportive housing program, who inject opioids.
Study NCT06432231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low glycemic index diet treatment
Description: This study was a non-randomized, single centre, pre/post-intervention study. A low glycemic index diet was prescribed by a dietician for 3 months. LGID treatment consisted of 10% (40-60 g) low glycaemic index (glycaemic index \<50) carbohydrate, 20-30% protein and 60-70% lipid
Study NCT05420597 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: Induction chemotherapy TP regimen combined with Toripalimab for 3 cycles: Toripalimab 240mg d1, Paclitaxel 175mg/m2 d2，Cisplatin 25mg/m2 d2-4 q3w. Then a total dose of 70Gy in 35 fractions was administered, with concurrently weekly cisplatin (30mg/m2 qw).~At 3-6 weeks post-radiotherapy, maintenance Toripalimab was administered for 8 cycles (240mg d1 q3w, in total 8 cycles).
Study NCT05645354 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SmokefreeSGM
Description: Participants will be enrolled in a text-based smoking cessation program specifically designed to respond to the needs of LGBTQ+ smokers.
Study NCT05645354 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SmokefreeTXT
Description: Participants will be enrolled in a text-based smoking cessation program specifically designed to respond to the needs of the general population
Study NCT05314738 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: NXL Energy 1
Description: Riboflavin drops + NXL System to Total Energy Level 1
Study NCT05314738 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: NXL Energy 2
Description: Riboflavin drops + NXL System to Total Energy Level 2
Study NCT05314738 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: NXL Energy 3
Description: Riboflavin drops + NXL System to Total Energy Level 3
Study NCT05314738 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: NXL Energy 3
Description: Riboflavin drops + NXL System to Total Energy Level 3
Study NCT05314738 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: SHAM_COMPARATOR
Intervention: Sham Treatment
Description: Sham Drops and No exposure to NXL system
Study NCT04810871 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Brain Surgery
Description: Undergo surgery
Study NCT05271383 — intervention group
Intervention type: DEVICE
Intervention: Orthognathic surgery using Global D's implants.
Description: Major or minor participants who will be treated by an orthognathic surgery with ORTRAUTEK® or MINITEK® implant(s).
Study NCT05455346 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound imaging
Description: Ultrasound B-mode images will be unilaterally collected from the biceps femoris muscle of the dominant limb for each participant using a commercial ultrasound system and linear array transducer. Standardized image locations will correspond to 33%, 50%, and 67% of the thigh length from the ischial tuberosity.~Three repeat longitudinal extended-field-of-view images of the entire biceps femoris muscle will be collected for offline analysis for fascicle length, muscle thickness, and pennation angle. Transverse extended-field-of-view images will be captured at the proximal, mid-belly, and distal locations to determine regional anatomical cross-sectional area of the biceps femoris long head muscle.~To determine changes in tissue stiffness via ultrasound shear wave speed, the same transducer will be placed in the same locations in a longitudinal view. Shear wave maps will be generated by the ultrasound system and shear wave speed measures extracted from the middle of the map.
Study NCT05455346 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ultrasound imaging
Description: Ultrasound B-mode images will be unilaterally collected from the biceps femoris muscle of the dominant limb for each participant using a commercial ultrasound system and linear array transducer. Standardized image locations will correspond to 33%, 50%, and 67% of the thigh length from the ischial tuberosity.~Three repeat longitudinal extended-field-of-view images of the entire biceps femoris muscle will be collected for offline analysis for fascicle length, muscle thickness, and pennation angle. Transverse extended-field-of-view images will be captured at the proximal, mid-belly, and distal locations to determine regional anatomical cross-sectional area of the biceps femoris long head muscle.~To determine changes in tissue stiffness via ultrasound shear wave speed, the same transducer will be placed in the same locations in a longitudinal view. Shear wave maps will be generated by the ultrasound system and shear wave speed measures extracted from the middle of the map.
Study NCT05455346 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hamstring Eccentric Strength Testing
Description: Prior to each test, participants will perform a standardized 5-minute general warm-up followed by a task-specific warm-up including 3 sets of submaximal trials. Load increases (5-20%) will be added for each RDL 3-repetition maximum trial attempt until the participant cannot complete 3 repetitions through the full range of motion using proper technique. A 3-minute rest will be administered between all warm-up and testing sets to allow for full recovery.~Participants will kneel on a commercial device used to assess maximum eccentric knee flexor strength via uniaxial load cells with their ankles secured into fixed hooks. Participants will slowly lower their torso to the ground with arms crossed across their chest and without bending at the hips or spine. The maximal test will consist of 1 set of 3 maximal repetitions. If participants can control lower themselves to the ground, then they will hold barbell plates (5-10 lb increments) across their chest while performing the NHE.
Study NCT05455346 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hamstring Eccentric Strength Testing
Description: Prior to each test, participants will perform a standardized 5-minute general warm-up followed by a task-specific warm-up including 3 sets of submaximal trials. Load increases (5-20%) will be added for each RDL 3-repetition maximum trial attempt until the participant cannot complete 3 repetitions through the full range of motion using proper technique. A 3-minute rest will be administered between all warm-up and testing sets to allow for full recovery.~Participants will kneel on a commercial device used to assess maximum eccentric knee flexor strength via uniaxial load cells with their ankles secured into fixed hooks. Participants will slowly lower their torso to the ground with arms crossed across their chest and without bending at the hips or spine. The maximal test will consist of 1 set of 3 maximal repetitions. If participants can control lower themselves to the ground, then they will hold barbell plates (5-10 lb increments) across their chest while performing the NHE.